An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme.
about
Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human gliomaImmune Checkpoint Modulators: An Emerging Antiglioma ArmamentariumImmunotherapy advances for glioblastomaImmunotherapy for primary brain tumors: no longer a matter of privilegeAn update on vaccine therapy and other immunotherapeutic approaches for glioblastomaAdoptive cell therapies for glioblastomaCombining Radiation Therapy with Immune Checkpoint Blockade for Central Nervous System MalignanciesTargeting immune checkpoints in malignant gliomaInherited variation in immune genes and pathways and glioblastoma riskMonitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patientsInflammation and Gliomagenesis: Bi-Directional Communication at Early and Late Stages of Tumor Progression.Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium.Treg depletion inhibits efficacy of cancer immunotherapy: implications for clinical trials.Dynamics of central and peripheral immunomodulation in a murine glioma model.Tumor specific regulatory T cells in the bone marrow of breast cancer patients selectively upregulate the emigration receptor S1P1.Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in gliomaThe presence of IL-17A and T helper 17 cells in experimental mouse brain tumors and human gliomaA Combination of Systemic and Intracranial Anti-CD25 Immunotherapy Elicits a Long-Time Survival in Murine Model of GliomaTumour-infiltrating T-cell subpopulations in glioblastomas.Immunotherapy of malignant gliomas using autologous and allogeneic tissue cells.Short hairpin RNA-mediated fibronectin knockdown delays tumor growth in a mouse glioma model.Overview of cellular immunotherapy for patients with glioblastoma.Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors.Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomasImmunotherapy coming of age: what will it take to make it standard of care for glioblastoma?Immunotherapy of brain cancers: the past, the present, and future directions.CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival.Molecular alterations in glioblastoma: potential targets for immunotherapy.OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy.Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumorsThrombin-processed Ecrg4 recruits myeloid cells and induces antitumorigenic inflammationRegulatory T cells are not a strong predictor of survival for patients with glioblastoma.Cellular-based immunotherapies for patients with glioblastoma multiforme.The evolution of the EGFRvIII (rindopepimut) immunotherapy for glioblastoma multiforme patientsRecent developments on immunotherapy for brain cancer.Immunotherapy for neuro-oncology: the critical rationale for combinatorial therapy.Differential correlation analysis of glioblastoma reveals immune ceRNA interactions predictive of patient survivalIDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survivalIsolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear CellsEpigenetic biomarkers of T-cells in human glioma.
P2860
Q24615166-CFA42EA5-C9C0-4B6C-9AA7-0047B74E7921Q26765459-26AE61AE-68AC-4963-A3C6-37A8305703E7Q26866513-D2986AA7-61B8-4201-BFC8-654DE9A4B803Q27002510-3E707A06-A6A3-4059-A35C-B84A63EFE9ECQ27024830-1CDD8CD2-9449-4E3C-A990-8DEFB4DDCDCEQ27030863-643C069C-6BCA-4E88-8BA8-4A0D79A7AC97Q28072007-B7DE689E-9E8D-4590-8266-D61300CC4FBEQ28072012-2117378A-15DF-448F-8C03-1A2A438C6729Q28383820-F8DE8135-8871-47B3-9956-53A20D0403BAQ28730798-144FE953-4569-416C-9623-1526A45BF922Q30414501-9523D0F9-E516-4D1D-BC03-0D32FAED5E34Q30481789-85DC0EB6-391B-4138-AFB4-71A052138A52Q33330270-ED1B8B2D-3083-414C-99B4-CD3B40C2E22EQ33410400-C2175E46-1AC1-4928-8DDC-CA6BD568C570Q33607086-B3BA1A22-A564-4482-822C-60613FA7BF22Q33613584-7A733925-5D71-45AB-8795-373631848FCDQ33741769-17326B5E-3468-419B-B9CC-B6E6AE7FD411Q33743905-CD3F429E-A32D-4CFE-9FBD-5DD2A0458DBAQ33943553-C99EB763-65D0-4251-94FD-5B1F80384B84Q34140756-8A3BC3CC-F0C7-4C7D-8726-D658E12F0AF3Q34177244-F9D2B931-C09C-452D-A209-E9827487E6D8Q34189694-2CA5B222-B0B7-4E17-81DF-F804659404EFQ34276759-C9CE0FF7-D586-4E03-9DDB-043ED4117DF5Q34399073-6B3A0E8A-0B66-4E9F-9B42-249777D81765Q34480557-E5E5A9CA-9ECB-4568-BCDA-010225DECCD8Q34701587-9DA63278-B39E-4E12-9D6C-9BA6C2AE4AEAQ34721530-EF9BDB89-BC5C-4B43-837E-3C7FFE127194Q34870511-C0634209-FEC1-4310-838F-B1AFC50C00A0Q35118177-F8E31E6A-CC24-4D1A-9E81-1EF1E6976F2CQ35570260-4C20BC4C-C8D5-45DE-9E30-FFC649DD446CQ35788583-A9C9212E-9A6B-4776-80D5-D6D41CCDED96Q35789008-C957A347-FC7B-4E44-A30D-A02E0730AA7AQ35821404-8A5EF669-F29B-4CA9-97CA-AA6C61C09CD6Q35886554-80CB709A-4A1F-4224-8E5E-25F26BFACE00Q35992355-640CCEB8-734D-4D10-BE2B-04CA7E9C0964Q36224057-AEC8A1F1-2F87-470C-9BFC-B39DADC3514DQ36292015-01D1A0E4-8AEB-415D-A9A4-7A00213BA1A9Q36405905-AB5F7C22-2975-417C-B8B8-5A09F9ABEA09Q36408364-45A3BAF1-2E0C-46C4-BA1B-271AA5A71BADQ36484129-1699B761-6801-42BE-8A5A-03570BA0F462
P2860
An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
An increase in CD4+CD25+FOXP3+ ...... human glioblastoma multiforme.
@ast
An increase in CD4+CD25+FOXP3+ ...... human glioblastoma multiforme.
@en
type
label
An increase in CD4+CD25+FOXP3+ ...... human glioblastoma multiforme.
@ast
An increase in CD4+CD25+FOXP3+ ...... human glioblastoma multiforme.
@en
prefLabel
An increase in CD4+CD25+FOXP3+ ...... human glioblastoma multiforme.
@ast
An increase in CD4+CD25+FOXP3+ ...... human glioblastoma multiforme.
@en
P2860
P1433
P1476
An increase in CD4+CD25+FOXP3+ ...... human glioblastoma multiforme.
@en
P2093
Abdeljabar El Andaloussi
Maciej S Lesniak
P2860
P304
P356
10.1215/15228517-2006-006
P577
2006-05-24T00:00:00Z